检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]重庆医科大学附属第一医院胸心外科,400016 [2]重庆医科大学核医学教研室,400016 [3]重庆市第三人民医院肿瘤科,400013
出 处:《重庆医学》2005年第6期892-893,896,共3页Chongqing medicine
摘 要:目的构建趋化因子受体CXCR4shRNA质粒重组体,并进行序列分析,为下一步探索肿瘤基因治疗的新途径打好基础。方法设计有小发夹结构的两条DNA序列。经退火成互补双链,再克隆至Psilencer2.1U6neo质粒载体中构建重组体,转化DH5а菌株,提取质粒行酶切鉴定后,进行测序分析。结果成功构建了CXCR4hRNA质粒重组体。结论CXCR4shRNA质粒重组体的成功构建为研究CXCR4靶向RNA干扰抗肿瘤的作用打下基础。Objective To construct the recombinant plasmid carrying shRNA to CXCR4 and analyze the nucleic acid sequence for further searching new gene therapy method of tumor.Methods Two DNA sequences containing small hairpin structure were designed and synthesized.The complement form was obtained by annealing and inserted into vector Psilencer2.1-U6 neo,and the recombinant plasmid was transformed into DH5a strain.Finally the plasmid identified by restriction enzyme Was used for sequence analysis.Results The recombinant psilencer2.1-U6 neo carrying shRNA to CXCR4 had been constructed and the aim sequence had been obtained.Conclusion The construction of the recombinant plasmid carrying shRNA to CXCR4 lays the basis for the study of its inhibitive effect on tumor.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28